RecruitingNCT06564571

Artificial Intelligence in Endoscopic Ultrasound

Sponsor

Orlando Health, Inc.

Enrollment

310 participants

Start Date

Jan 19, 2024

Study Type

OBSERVATIONAL

Conditions

Pancreatic Cancer Pancreatic Cyst Pancreas Disease

Summary

The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound procedures.

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating whether artificial intelligence (AI) software can assist doctors in interpreting endoscopic ultrasound (EUS) images — a procedure that uses sound waves to look inside the digestive tract and surrounding organs — to improve the accuracy and speed of diagnosis. **You may be eligible if...** - You are 18 or older - You are already scheduled to have an endoscopic ultrasound procedure as part of your regular medical care **You may NOT be eligible if...** - You are under 18 years old Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPatients undergoing endoscopic ultrasound procedures

Patients will undergo endoscopic ultrasound procedures as planned. Abnormalities in the pancreas identified by the endoscopist during the endoscopic ultrasound examination will be correlated against those detected by the AI platform.

Locations(1)

Orlando Health

Orlando, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06564571

Related Trials

DESTINY-PANTUMOUR04

NCT0712400017 locations

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

NCT0725223217 locations

In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers

NCT072063551 location

Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery

NCT054283583 locations

Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers

NCT028388361 location